Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3H-10000 in Advanced Solid Tumors
NCT07354711Phase 2Recruiting
- Sponsor
- 3H Pharmaceuticals
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of 3H-10000 in lung cancer, gastric cancer (GC), sponsored by 3H Pharmaceuticals. Started Jan 2026; status: recruiting.
02
Drugs
3H-10000
03
Conditions
lung cancergastric cancer (GC)
Beyond the preview
Go deeper on NCT07354711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07354711.